397 related articles for article (PubMed ID: 26245651)
1. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
2. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
4. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
6. Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Garcia I; Mayol G; Rodríguez E; Suñol M; Gershon TR; Ríos J; Cheung NK; Kieran MW; George RE; Perez-Atayde AR; Casala C; Galván P; de Torres C; Mora J; Lavarino C
Mol Cancer; 2010 Oct; 9():277. PubMed ID: 20950435
[TBL] [Abstract][Full Text] [Related]
7. Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-gamma.
Shikata A; Shikata T; Sotozono Y; Hosoi H; Matsumura T; Sugimoto T; Sawada T
Med Pediatr Oncol; 2000 Jun; 34(6):394-401. PubMed ID: 10842245
[TBL] [Abstract][Full Text] [Related]
8. Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.
Eggert A; Ho R; Ikegaki N; Liu XG; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):623-7. PubMed ID: 11107132
[TBL] [Abstract][Full Text] [Related]
9. [Neuronal differentiation and TrkA expression of neuroblastoma induced by the combination treatment of interferon-gamma and NGF].
Wang H; Zhang JH; Mi Z
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):180-3. PubMed ID: 15144710
[TBL] [Abstract][Full Text] [Related]
10. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.
Yamaguchi Y; Tabata K; Asami S; Miyake M; Suzuki T
Biol Pharm Bull; 2007 Apr; 30(4):638-43. PubMed ID: 17409494
[TBL] [Abstract][Full Text] [Related]
11. TrkA signal transduction pathways in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Chou TT; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):108-10. PubMed ID: 11464858
[TBL] [Abstract][Full Text] [Related]
12. Regulation of NGF responsiveness in human neuroblastoma.
Bogenmann E; Peterson S; Maekawa K; Matsushima H
Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.
Naraparaju K; Kolla V; Zhuang T; Higashi M; Iyer R; Kolla S; Okawa ER; Blobel GA; Brodeur GM
Oncotarget; 2016 Mar; 7(13):15977-85. PubMed ID: 26895110
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.
Singh A; Rokes C; Gireud M; Fletcher S; Baumgartner J; Fuller G; Stewart J; Zage P; Gopalakrishnan V
Cancer; 2011 Nov; 117(22):5189-202. PubMed ID: 21523764
[TBL] [Abstract][Full Text] [Related]
15. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells.
Poluha W; Poluha DK; Ross AH
Oncogene; 1995 Jan; 10(1):185-9. PubMed ID: 7824271
[TBL] [Abstract][Full Text] [Related]
16. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
Woo CW; Lucarelli E; Thiele CJ
Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
[TBL] [Abstract][Full Text] [Related]
17. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
[TBL] [Abstract][Full Text] [Related]
18. Elevated TrkA receptor expression is associated with all-trans retinoic acid-induced neuroblastoma differentiation.
Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
Genet Mol Res; 2015 Oct; 14(4):13195-202. PubMed ID: 26535632
[TBL] [Abstract][Full Text] [Related]
19. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of CHD5 Inactivation in neuroblastomas.
Koyama H; Zhuang T; Light JE; Kolla V; Higashi M; McGrady PW; London WB; Brodeur GM
Clin Cancer Res; 2012 Mar; 18(6):1588-97. PubMed ID: 22294723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
